Your stock moved. Here's why.
Big stock moves explained in plain English, usually within hours.
Latest moves
- CART Up 9.2% EXPLAINERDEVELOPING
Instacart jumps 9% on reports it is exploring a sale; Uber reportedly out
Reports say Instacart is exploring a sale and has talked to DoorDash and Uber. Nothing is confirmed. What we know, who could buy it and what to watch.
- WGS Up 4428% since Nov 2023 TREND
GeneDx rose 135-fold on genome tests, then lost 66% on pay fears
GeneDx rose from $1.24 in 2023 to $167 by betting on rare-disease DNA tests, then lost about two-thirds as payments per test fell short.
- BE Down 11.2%
Bloom Energy sinks 11% as record sales come with a cash burn
Bloom Energy beat forecasts and raised guidance, but its record quarter used $181 million of cash after a huge run, and the stock fell about 11%.
- CORT Down 20.1%
Corcept falls 20% as a rival ovarian cancer drug aces its Phase 3 trial
Corcept had no news of its own. Genmab's Rina-S beat chemotherapy in the same ovarian cancer market as Corcept's new growth drug, Lifyorli.
- TNGX Down 16.4%
Tango Therapeutics falls 16% despite strong pancreatic cancer data
Tango's pancreatic cancer combination shrank tumors in 82% of patients, but the stock fell after a run-up into the data, with a Phase 3 trial still more than a year away.
- AI BUILD‑OUT Down 53% median of 66 BIG PICTURE
AI's borrowed boom: why 66 AI build-out stocks have lost about $2 trillion
As lenders grew warier and doubts about AI returns spread, Oracle, CoreWeave, SanDisk and 63 other AI build-out stocks lost about $2 trillion in market value.
- CYATY Down 54.2% since Jun TREND
CATL falls 54% since June as taxes squeeze profit and customers move
CATL's Hong Kong shares have lost more than half their value since June as new battery taxes squeeze profit and carmakers shift orders to rivals.
- GEV Down 10.64%
GE Vernova sinks 11% on Meta's AI spending scare, not its own news
GE Vernova had no news of its own. It fell with other AI power stocks after Meta's results raised doubts about who pays for the AI build-out.
- META Down 6.98%
Meta falls 7% as AI spending outruns the cash its business makes
Meta beat forecasts, but AI spending pushed its free cash flow below zero, and it created new shares it could sell to fund more.
- MRNA Down 17.6%
Moderna falls 18% as strong cancer-vaccine data misses sky-high hopes
Moderna's cancer vaccine worked, but results leaked and confirmed the same day fell short of hopes built into a stock up about 8× this year before the drop.